[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
August 1980

Topically Applied Fluocinonide in an Adhesive Base in the Treatment of Oral Vesiculoerosive Diseases

Author Affiliations

From the Department of Oral Medicine and Hospital Dentistry, University of California School of Dentistry, San Francisco.

Arch Dermatol. 1980;116(8):898-901. doi:10.1001/archderm.1980.01640320048012

• Patients with oral vesiculoerosive diseases frequently require corticosteroid treatment to induce healing and reduce pain. Because of the adverse effects associated with systemic use, topical application of 0.05% fluocinonide in an adhesive base was investigated. The study group was comprised of 89 patients with erythema multiforme, lichen planus, benign mucous membrane pemphigoid, or pemphigus. In the double-blind phase involving 15 patients, seven responded completely and eight partially to the topical ointment. In the open study that included 74 patients, 35 had complete disappearance of signs and symptoms, while 39 experienced partial benefit. There were no adverse side effects. All 89 patients were observed for three to 35 months and each patient's condition continued to respond to the treatment when its use was required.

(Arch Dermatol 116:898-901, 1980)